Model
Edge
Nabriva Therapeutics
0001732196
Filing Type
4
Filing Date
8/2/2022
Updated
8/3/22, 3:46 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership